It’s not just insulin: Lawmakers
focus on price of one drug, while others rise too |
|||
Kaiser Health News |
|||
Michael Costanzo, a Colorado farmer diagnosed with multiple
sclerosis in 2016, has a well-honed ritual: Every six months, he takes an IV
infusion of a medicine, Rituxan, to manage his disease, which has no cure.
Then he figures out how to manage the bill, which costs thousands of dollars.
For a time, the routine held steady: The price billed to his health insurance
for one infusion would cost $6,201 to $6,841. Costanzo’s health insurance
covered most of it, and he paid the rest out-of-pocket. |
|||
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, September 23, 2020
It’s not just insulin: Lawmakers focus on price of one drug, while others rise too
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment